Profil
Mr. Peter Buetikofer is a Chairman-Investment Committee & Board Member at Solidum Partners AG.
Since 1983 he works for Swiss Reinsurance Company, first as an underwriter and from 2005 until 2017 as managing director, responsible for the Property Center Reinsurance and serving as deputy chief underwriting officer non-life reinsurance.
In anticipation of his retirement, he stepped down from his managerial functions and currently serves as executive advisor property underwriting for large and complex structures.
He has a master's degree in statistics and actuarial sciences.
Aktive Positionen von Peter Buetikofer
| Unternehmen | Position | Beginn |
|---|---|---|
Solidum Partners AG
 Solidum Partners AG Investment ManagersFinance Solidum Partners AG is an independent investment management firm headquartered in Zurich, Switzerland. It was founded by Stefan Mueller in 2004 and is managed by its partners since a management buyout in 2006. The firm offers advisory and portfolio management services for investments in insurance linked securities (ILS) and manages UCITS funds that are licensed for public distribution in various countries as well as alternative investments funds aimed at institutional investors. | Chief Investment Officer | 26.08.2019 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Solidum Partners AG
Solidum Partners AG Investment ManagersFinance Solidum Partners AG is an independent investment management firm headquartered in Zurich, Switzerland. It was founded by Stefan Mueller in 2004 and is managed by its partners since a management buyout in 2006. The firm offers advisory and portfolio management services for investments in insurance linked securities (ILS) and manages UCITS funds that are licensed for public distribution in various countries as well as alternative investments funds aimed at institutional investors. | Finance |
